TY - JOUR
AU - Torp-Pedersen, Christian
AB - Objectives: To examine whether treatment with clarithromycin was associated with an increased risk of death in patients with preexisting ischemic heart disease (IHD). Methods: Employing nationwide registers, all patients with IHD events from 1997 to 2007 who subsequently claimed prescriptions for dual antibiotic treatment for eradication treatment were identified. The primary endpoint was all-cause mortality. Results: The study included 214,330 individuals with IHD; 5,265 (2.5 %) of these claimed prescriptions for dual antibiotics. Compared with IHD patients not undergoing eradication therapy, no increase in the risk of all-cause mortality was demonstrated (HR 1.02; 95% CI 0.84–1.23, p = 0.87) after 5 years. Conclusions: The use of clarithromycin in the setting of eradication treatment for Helicobacter pylori in patients with IHD was not associated with an increased risk of death.
TI - Clarithromycin Use and Risk of Death in Patients with Ischemic Heart Disease
JF - Cardiology
DO - 10.1159/000315394
DA - 2010-01-01
UR - https://www.deepdyve.com/lp/karger/clarithromycin-use-and-risk-of-death-in-patients-with-ischemic-heart-nsQLfPLOJE
SP - 89
EP - 97
VL - 116
IS - 2
DP - DeepDyve
ER -